Officials with the Drug Enforcement Administration (DEA) are reportedly resisting calls to reschedule marijuana, creating tension with the White House as President Joe Biden continues to tout his role in directing the cannabis review.
That's according to an article published by The Wall Street Journal on Saturday, with the report citing "people familiar with the matter" who say certain DEA officials are disputing scientific findings from the U.S. Health and Human Services (HHS) that led it to recommend moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).
Some advocates and stakeholders have challenged...
Login or create a forever free account to read this news
Sign up/Log in